# Bioequivalence Study of CRushed TriUMeq With or Without Drip Feed Compared to the Whole Tablet

> **NCT02569346** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 22 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Triumeq
- **DRUG:** Triumeq crushed + breakfast
- **DRUG:** Triumeq crushed + drip feed

## Key facts

- **NCT ID:** NCT02569346
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02569346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02569346, "Bioequivalence Study of CRushed TriUMeq With or Without Drip Feed Compared to the Whole Tablet". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02569346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*